Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

The AIDS Society of India (ASI) has called on the government to swiftly integrate HIV self-testing and pre-exposure ...

Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product ... women – those who identify with the gender they were born with – contracted HIV while on the drug. Hasina Subedar, senior ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.

(HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and ... Generic TDF/FTC reached the highest monthly share of users among all medications from December 2021 to December ...

Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.